Canada
-
Health Canada seeks input on new drug review process
Proposed framework would allow Canadian regulator to use drug approval decisions from foreign agencies to speed up approvals in Canada.
-
FINTRAC confirms details of tougher AML regime
Under the new rules, FINTRAC may impose much higher maximum penalties and make greater use of formal tools to force firms to fix compliance problems.
-
GRIP Extra: CFTC replaces outdated swap benchmarks, ESMA moves to simplify EU reporting
Our in-brief roundup of notable stories from the last week.
-
SEC proposes letting public companies move to semiannual reporting
The proposal is the biggest reformulation of reporting rules in decades.
-
US ESG roundup: Global standards and the Clean Air Act
ESG has not disappeared, it has reconfigured into enduring laws, regional pressure, and global nonbinding standards that continue to shape outcomes.
-
CIRO issues penalties, citing gatekeeper failures
CIRO alleges a firm failed to adequately supervise the US over-the-counter securities trading by two foreign broker-dealer clients.
-
GRIP Extra: OCC blocks Illinois interchange fee ban, CFPB cuts small business lending rule
Our in-brief roundup of notable stories from the last week.
-
Canada’s sanctions guidance for aerospace and defense sectors
Some of the sanctions best practices offered here apply to businesses in multiple industry sectors trying to manage sanctions risks more effectively.